Loading...
Almirall, S.A.
LBTSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.75
$-3.61(-27.02%)
Almirall, S.A. (LBTSF) Financial Performance & Income Statement Overview
Review Almirall, S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.20%
↑ 10.20%
Operating Income Growth
785.52%
↑ 785.52%
Net Income Growth
126.37%
↑ 126.37%
Operating Cash Flow Growth
71.97%
↑ 71.97%
Operating Margin
5.86%
↑ 5.86%
Gross Margin
78.30%
↑ 78.30%
Net Profit Margin
2.38%
↑ 2.38%
ROE
1.64%
↑ 1.64%
ROIC
2.91%
↑ 2.91%
Almirall, S.A. (LBTSF) Income Statement & Financial Overview
Review Almirall, S.A.'s (LBTSF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $286.10M | $258.12M | $230.38M | $248.42M |
| Cost of Revenue | $94.20M | -$38.26M | $149.37M | $16.73M |
| Gross Profit | $191.90M | $296.38M | $81.01M | $231.69M |
| Gross Profit Ratio | $0.67 | $1.15 | $0.35 | $0.93 |
| R&D Expenses | $35.50M | -$11.10M | $52.04M | $11.66M |
| SG&A Expenses | $91.30M | -$124.63M | $194.42M | -$50.22M |
| Operating Expenses | $157.70M | $288.11M | $81.01M | $231.69M |
| Total Costs & Expenses | $251.90M | $249.85M | $230.38M | $248.42M |
| Interest Income | $2.00M | $1.69M | $1.75M | $0.00 |
| Interest Expense | $3.80M | $4.82M | $0.00 | $0.00 |
| Depreciation & Amortization | $36.70M | $35.38M | $35.10M | $34.60M |
| EBITDA | $76.30M | $29.90M | $40.71M | $84.69M |
| EBITDA Ratio | $0.27 | $0.12 | $0.18 | $0.34 |
| Operating Income | $34.20M | $8.27M | $0.00 | $53.03M |
| Operating Income Ratio | $0.12 | $0.03 | $0.00 | $0.21 |
| Other Income/Expenses (Net) | $1.60M | -$10.37M | -$1.67M | -$37.86M |
| Income Before Tax | $35.80M | -$2.10M | -$1.67M | $15.17M |
| Income Before Tax Ratio | $0.13 | -$0.008 | -$0.007 | $0.06 |
| Income Tax Expense | $14.20M | -$5.05M | $6.52M | $7.18M |
| Net Income | $21.60M | $2.95M | -$8.19M | $7.99M |
| Net Income Ratio | $0.08 | $0.01 | -$0.04 | $0.03 |
| EPS | $0.10 | $0.01 | -$0.04 | $0.03 |
| Diluted EPS | $0.10 | $0.01 | -$0.04 | $0.04 |
| Weighted Avg Shares Outstanding | $213.25M | $213.47M | $234.10M | $234.10M |
| Weighted Avg Shares Outstanding (Diluted) | $213.25M | $213.47M | $213.47M | $213.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan